We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.45B
AUM Growth
-$164M
Cap. Flow
-$92.8M
Cap. Flow %
-6.4%
Top 10 Hldgs %
36.09%
Holding
256
New
32
Increased
41
Reduced
35
Closed
116

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$26.6M
2
AB icon
AllianceBernstein
AB
+$19.8M
3
CNC icon
Centene
CNC
+$16M
4
GXO icon
GXO Logistics
GXO
+$12.5M
5
AMTM
Amentum Holdings
AMTM
+$12M

Top Sells

Rank Stock Value
1
OXY.WS icon
Occidental Petroleum Corp Warrants
OXY.WS
+$23.5M
2
C icon
Citigroup
C
+$14.1M
3
TGTX icon
TG Therapeutics
TGTX
+$13.5M
4
CVNA icon
Carvana
CVNA
+$11.7M
5
ERO icon
Ero Copper
ERO
+$8.91M

Sector Composition

Rank Sector Weight
1 Healthcare 23.58%
2 Consumer Discretionary 8.63%
3 Financials 6.56%
4 Industrials 5.44%
5 Technology 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIDU icon
26
Baidu
BIDU
$38.2B
$16.3M 1.13%
177,500
+7,500
+4% +$673K
CNC icon
27
Centene
CNC
$31.8B
$16.1M 1.11%
+265,000
New +$16M
ALNY icon
28
PUT
Alnylam Pharmaceuticals
ALNY
$29.2B
$13.8M 0.95%
51,200
-7,500
-13% -$1.93M
INSE icon
29
Inspired Entertainment
INSE
$186M
$13.4M 0.92%
1,563,552
-136,448
-8% -$1.31M
LEN.B icon
30
Lennar Class B
LEN.B
$20.6B
$12.5M 0.87%
115,000
-5,980
-5% -$713K
ELV icon
31
Elevance Health
ELV
$82.6B
$11.7M 0.81%
+27,000
New +$10.8M
TGTX icon
32
TG Therapeutics
TGTX
$7.32B
$11.6M 0.8%
295,000
-402,000
-58% -$13.5M
PDD icon
33
Pinduoduo
PDD
$130B
$11.2M 0.78%
95,000
– –
KNOP icon
34
KNOT Offshore Partners
KNOP
$362M
$11.2M 0.78%
1,610,000
– –
SRPT icon
35
Sarepta Therapeutics
SRPT
$1.72B
$10.5M 0.73%
165,000
+63,000
+62% +$6.63M
XHR
36
Xenia Hotels & Resorts
XHR
$1.88B
$10.5M 0.72%
890,000
-111,990
-11% -$1.56M
ITOS
37
DELISTED
iTeos Therapeutics
ITOS
$10.4M 0.72%
1,750,000
+831,883
+91% +$6.11M
MREO
38
Mereo BioPharma
MREO
$51.6M
$10.4M 0.72%
4,635,000
+85,000
+2% +$240K
ASML icon
39
ASML
ASML
$653B
$10.4M 0.72%
15,650
– –
HRMY icon
40
Harmony Biosciences
HRMY
$2.27B
$9.96M 0.69%
300,000
– –
MRP
41
Millrose Properties Inc
MRP
$4.89B
$9.41M 0.65%
+355,000
New +$8.31M
CZR icon
42
Caesars Entertainment
CZR
$6.12B
$9.38M 0.65%
375,000
+73,100
+24% +$2.38M
ZVRA icon
43
Zevra Therapeutics
ZVRA
$608M
$9.18M 0.63%
1,225,834
– –
CRESY
44
Cresud
CRESY
$772M
$9.17M 0.63%
837,021
-55,466
-6% -$644K
PHAT icon
45
Phathom Pharmaceuticals
PHAT
$690M
$9.06M 0.62%
1,445,000
+420,000
+41% +$2.55M
HHH icon
46
Howard Hughes
HHH
$3.93B
$8.89M 0.61%
120,000
-15,000
-11% -$1.13M
LEN icon
47
PUT
Lennar Class A
LEN
$20.9B
$8.61M 0.59%
75,000
-17,970
-19% -$2.24M
AMLX icon
48
Amylyx Pharmaceuticals
AMLX
$2.46B
$8.54M 0.59%
2,411,400
+481,400
+25% +$1.71M
WAL icon
49
Western Alliance Bancorporation
WAL
$9.3B
$8.45M 0.58%
110,000
+10,000
+10% +$840K
IOVA icon
50
Iovance Biotherapeutics
IOVA
$1.98B
$7.99M 0.55%
2,400,000
+983,986
+69% +$5.07M
1
2
3 4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, 683 Capital Management held 256 positions worth $1.45B, down 10% from $1.61B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

683 Capital Management withdrew a net $92.8M in Q1 2025, closing 116 positions and reducing 35 holdings. Its most notable exit was Occidental Petroleum Corp Warrants, an estimated $23.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in UnitedHealth worth $27.2M.

  • 683 Capital Management's largest Q1 2025 buy was UnitedHealth: 52,000 shares worth $27.2M.
  • 683 Capital Management added most to GXO Logistics in Q1 2025, an estimated $12.5M increase.
  • 683 Capital Management's biggest Q1 2025 reduction was TG Therapeutics, cutting an estimated $13.5M.
  • 683 Capital Management fully exited Occidental Petroleum Corp Warrants in Q1 2025, selling an estimated $23.5M.
  • 683 Capital Management's ten largest holdings make up 36% of its $1.45B portfolio in Q1 2025.
  • 683 Capital Management opened 32 new positions and closed 116 in Q1 2025.
  • 683 Capital Management's portfolio value fell 10% quarter-over-quarter to $1.45B.

Based on 683 Capital Management's 13F filing for Q1 2025, filed 15 May 2025.